1. Name of goods: Free dividends, but ro insurance (securities number B);

2. Insurance period: November 25, 2008 to November 25, 2069.

1.In recognition, Article 3 (Definition and Diagnosis Confirmation of Boundary Species) 1 of this Agreement refers to the disease that is classified as either an unidentified or an aesthetic organism in the fifth Korean Standard Disease Classification.

② 경계성 종양의 진단 확정은 해부병리 또는 임상병리의 전문의사 자격증을 가진 자에 의하여 내려져야 하며, 이 진단은 조직(fixed tissue)검사, 미세침흡인검사(fine needle aspiration biopsy) 또는 혈액(hemic system)검사에 대한 현미경 소견을 기초로 하여야 합니다.

However, if it is not possible to conduct the above pathological diagnosis, the clinical diagnosis of the species of boundary is admitted as evidence of the form of boundary.

In this case, there shall be a documented record or evidence proving that the insured has been diagnosed or treated in the form of a security. A.

On November 25, 2008, the insurance contract between the Plaintiff and the Defendant was concluded, and the insurance terms and conditions set forth as follows with respect to the boundaryal species (the boundary or intermediate stages of malicious species and cultivation).

B. On January 26, 2015, the Defendant was issued a final diagnosis of the presumption of “the pattern of conduct in the internal rain line or the aesthetic Organisms (Korean Standard Disease Disease Classification Code 44)” at the D’s level located in the following cities: (a) on February 11, 2015, at the university hospital of the original Mine University, the Defendant was issued a final diagnosis of “the diagnostic image of the other specified physical structure”.

【Reasons for Recognition】 Each entry of Gap evidence Nos. 1 and 4, the purport of the whole pleadings

2. The fact that the Defendant, at the D Council on January 26, 2015, was diagnosed by the presumption of the “inception pattern of internal decentralization” or the “inception organism” (Korean Standard Disease Classification Code D44) through blood test and ultra-wave test is recognized.

On the other hand, in the terms and conditions of insurance, the insured is in terms of tissue testing, spawnying test, or blood test.